News Details
South Korea consults for the draft amendment on the Guidelines for Clinical trials on cosmetics that alleviate hair loss symptoms
National Institute of Food and Drug Safety Evaluation (NIFDS) in South Korea consults on a draft amendment on the Guidelines for Clinical trials on cosmetics that alleviate hair loss symptoms on October 14th, 2022. This is to clarify required fields to be included in the clinical trial report.
The guidelines mentions that the clinical trial report should follow the “Regulations on the demonstration of cosmetic labeling and advertising”. The clinical trial report is recommended to include the following criteria:
- Title of the test
- Testing institute information
- Test and control substance information
- Subject control and test method
- Test results
- Methods of synthesizing results
- Data reliability
- Side effect and measurement details
If you have any opinion on this draft amendment, please write your opinion in the provided format and submit it to Korea Cosmetic Association.
The deadline for this consultation is Oct 20th, 2022.
We acknowledge that the above information has been compiled from KCIA.
Global Product Compliance (GPC) specializes in Global Regulatory Compliance Solutions across sectors
globally. SSS Europe, a familiar name in chemical regulatory and compliance services now formally belongs
under the umbrella of GPC Holding Sweden.
Since 2008, we have emerged as one of the leading names among Global Regulatory Compliance Service
Providers with Representation services in Europe, Asia and Middle East for respective chemical
regulations.
